id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-305264-0uhabgsr	Weng, C-H.	Bacillus Calmette–Guérin vaccination and clinical characteristics and outcomes of COVID-19 in Rhode Island, United States: a cohort study	2020-07-09		.txt	text/plain	1528	94	49	In this study, we reviewed 120 consecutive adult patients (≥18 years old) with COVID-19 at a major federally qualified health centre in Rhode Island, United States from 19 March to 29 April 2020. To determine if BCG vaccination provided protection from COVID-19, we reviewed a predominately Latino/Hispanic population receiving care at the major federally qualified health centre (FQHC) in Providence, Rhode Island, United States. COVID-19 patients with BCG vaccination were less likely to be hospitalised during the disease course (3.7% vs. A recent population-based study examining the cohort of Israeli adults aged 35−41 years found that the BCG vaccine may not reduce the likelihood of acquiring SARS-CoV-2 (difference, 1.3%; 95% CI −0.3% to 2.9%; P = 0.09) [10] . However, the lower hospitalisation rate among BCG-vaccinated patients from our prospective cohort study suggests the potential of BCG in preventing more severe COVID-19 among those who acquired SARS-CoV-2.	./cache/cord-305264-0uhabgsr.txt	./txt/cord-305264-0uhabgsr.txt